Treatment of lung cancer
240 results
1 - 100
Treatment of lung cancer 
Elemene for the treatment of lung cancer: Cochrane systematic review- First‐line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non‐squamous non‐small cell lung cancer
- Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) plus platinum‐etoposide versus platinum‐etoposide alone for first‐line treatment of extensive small cell lung cancer
- Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non‐small‐cell lung cancer and EGFR mutation
- Immune checkpoint inhibitors plus platinum‐based chemotherapy compared to platinum‐based chemotherapy with or without bevacizumab for first‐line treatment of older people with advanced non‐small cell lung cancer
- Chemotherapy versus best supportive care for extensive small cell lung cancer: Cochrane systematic review
- Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission: Cochrane systematic review
- Interventions for smoking cessation in people diagnosed with lung cancer
- Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer: Cochrane systematic review
- Cisplatin versus carboplatin in combination with third‐generation drugs for advanced non‐small cell lung cancer
- Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): Cochrane systematic review
- Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer
Spiral CT detects early lung cancer, but screening use is premature- Surgery versus radiosurgery for patients with a solitary brain metastasis from non‐small cell lung cancer
- Surgery for local and locally advanced non‐small cell lung cancer
- Lung cancers
- Screening for lung cancer
- Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non‐small cell lung cancer
- Gefitinib for advanced non-small cell lung cancer: Cochrane systematic review
- Chemotherapy for non‐small cell lung cancer
- Exercise training for advanced lung cancer
- Surgery for limited‐stage small‐cell lung cancer
- Second‐line chemotherapy for non‐small cell lung cancer
- Chemotherapy for brain metastases from small cell lung cancer: Cochrane systematic review
- Non‐invasive interventions for improving well‐being and quality of life in patients with lung cancer
- Postoperative radiotherapy for non‐small cell lung cancer
- Therapeutic vaccines for advanced non‐small cell lung cancer
- Platinum-based chemotherapy regimens for small-cell lung cancer
- Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer
- Adjuvant chemotherapy for resected early-stage non-small cell lung cancer: Cochrane systematic review
- Palliative endobronchial brachytherapy for non‐small cell lung cancer
- Biosimilar monoclonal antibodies for cancer treatment in adults
- Prophylactic cranial irradiation for extensive‐stage small cell lung cancer
- Early versus late chest radiotherapy in patients with limited‐stage small cell lung cancer
- Problems of childhood or adolescence cancer survivors in adulthood
- Palliative radiotherapy regimens for patients with thoracic symptoms from non‐small cell lung cancer
- PET‐CT for assessing mediastinal lymph node involvement in patients with suspected resectable non‐small cell lung cancer
- Telehealth is effective for providing palliative care to adults with advanced lung cancer
- Platinum versus non‐platinum chemotherapy regimens for small cell lung cancer
- Systematic review: lung cancer screening with CT decreases mortality but with significant harms
- Population screening for cancer
- Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer: Cochrane systematic review
- Best first‐line therapy for people with advanced non‐small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status
- Chemotherapy versus best supportive care for extensive small cell lung cancer
- Oncological emergencies
- Bone tumours
- Surgical sealant for preventing air leaks after pulmonary resections in patients with lung cancer: Cochrane systematic review
- Concurrent chemoradiotherapy in non-small cell lung cancer
- Chemotherapy for advanced non‐small cell lung cancer in the elderly population
- Chemotherapy and surgery versus surgery alone in non‐small cell lung cancer
- Exercise training undertaken by people within 12 months of lung resection for non‐small cell lung cancer
- Interventions for cough in cancer
- Long-term adverse effects of antineoplastic agents
- Immunotherapy (excluding checkpoint inhibitors) for stage I to III non‐small cell lung cancer treated with surgery or radiotherapy with curative intent
- Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: Cochrane systematic review
- PSA screening does not reduce mortality from prostate CA (PLCO)
- Asbestos-related diseases
- Brain and spinal cord tumours
- Parenteral anticoagulation in ambulatory patients with cancer
- Erythropoietin or Darbepoetin for patients with cancer ‐ meta‐analysis based on individual patient data
- Pleurodesis for malignant pleural effusions: Cochrane systematic review
- Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients
- Biomedical risk assessment as an aid for smoking cessation